Table 2.

Summary of the non-fatal human intoxication case with 5-MeO-MiPT reported by Pavia Poison Control Centre—National Toxicology Information Centre

Eds admission	Age (year), sex, type	Anamnestic data	Symptoms and clinical presentation	Management/therapy	Blood/urine analyses: analytical findings*	Hospital stay and outcome
July 2022; Northern Italy Hospital	23, male, non-fatal intoxication	Pre-existing depressive disorder (pharmacological therapy: sertraline and alprazolam)	- Tachycardia - Catatonia - Slowdown - Drowsiness - Muteness	Symptomatic treatment	5-MeO-MiPT; 4F-MPH; DCK #	24 h Discharged home

4-F-MPH, 4-fluoromethylphenidate; DCK, deschloroketamine

*GC/MS and LC–MS/MS methods

#Tested negative for the following substances: butylone, eutylone, ephylon, mephedrone, clephedrone, methylcathinone, dimethylcathinone, N-ethylpentedrone, MDPEP, dimethylmethcathinone, buphedrone, ethcathinone, 4-fluoromethcathinone, pentedrone, methedrone, mexedrone, ethylone, pentylone, naphyrone, methylone, α-PHP, 3,4-MDPHP, α-PVP, MDPV, betaK-2CB, PMA, PMMA, 4-fluoroamphetamine, 4-MTA, ketamine, 2-fluoroketamine, OH-PCP, OH-PCE, MeO-PCE, MeO-PCP, OXO-PCE, levamisole, scopolamine, atropine, (aminopropyl)benzofurans, 5-EAPB, 5/6-MAPB, 4-OH-DET, 5-MeO-DALT, 5-Meo-DMT, methylphenidate, ethylphenidate, phencyclidine, methoxetamine, methoxphenidine, diphenidine, dimethyltryptamine, 2C-I, 2C-T7, 2C-B, 2C-T2, 2C-E, DOB, 25B-NBOMe, 25C-NBOMe, 25I-NBOMe, 25H-NBOMe, 25T7-NBOMe, 25D-NBOMe, and 25E-NBOMe